Details for New Drug Application (NDA): 050613
✉ Email this page to a colleague
NDA 050613 describes CEFOBID IN PLASTIC CONTAINER, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the CEFOBID IN PLASTIC CONTAINER profile page.
The generic ingredient in CEFOBID IN PLASTIC CONTAINER is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
The generic ingredient in CEFOBID IN PLASTIC CONTAINER is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
Summary for 050613
| Tradename: | CEFOBID IN PLASTIC CONTAINER |
| Applicant: | Pfizer |
| Ingredient: | cefoperazone sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050613
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/ML | ||||
| Approval Date: | Jul 23, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | Jul 31, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
